Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

The benefits of matrix regenerative therapy in progressive corneal thinning due to various causes - case series

Poster Details

First Author: E.Mrukwa-Kominek POLAND

Co Author(s):    M. Sarnat-Kucharczyk              

Abstract Details


To presents results of novel therapy application in patients with progressive corneal thinning. To evaluate the usefulness of this therapy.


Department of Ophthalmology, University Center of Ophthalmology and Oncology, Medical University of Silesia, Katowice, Poland


In above mentioned entities persistent inflammatory process, wound healing defect, factors such as stress, surgical trauma, infection or drug side effects have caused significant damage of corneas. Corneal stroma regenerant contributed to persistent corneal ulcers healing. It promoted epithelialization and supported further reconstruction of the corneal stroma. Patients displayed significant improvement in corneal thickness and in visual acuity after novel therapy introduction. No systemic or local side effects of the treatment were reported.


Despite the advancement of ophthalmology progressive corneal thinning, which may be secondary to systemic or eye diseases, is difficult to treat and is often resistant to medications. RGTA stopped the progression of corneal thinning and enhanced matrix regeneration. It has appeared to be potentially useful, alternative, noninvasive therapeutic approach in progressive corneal thinning.



Financial Disclosure:


Back to Poster listing